Little MP, Kleinerman RA, Li G, Stiller CA, Kroll ME & Murphy MF. (2011). Analysis of retinoblastoma age incidence data using a fully stochastic cancer model. Int J Cancer, 130 631-40

O'Neill KA, Bunch KJ, Vincent TJ, Spector LG, Moorman AV & Murphy MFG. (2011) Immunophenotype and cytogenetic characteristics in the relationship between birth weight and childhood leukemia. Pediatr Blood Cancer, 58 7-11.

Lycett D, Munafò MR, Johnstone E, Murphy MFG & Aveyard P. (2011) Weight change over eight years in relation to alcohol consumption in a cohort of continuing smokers and quitters. Nicotine Tob Res 13 1149-1154.

Shah A, Diggens N, Stiller C, Murphy D, Passmore J & Murphy MF. (2011). Place of death and hospital care for children who died of cancer in England, 1999-2006. Eur J Cancer., 47 2175-2181.

Munafò MR, Johnstone EC, Walther D, Uhl GR, Murphy MFG & Aveyard P. (2011). CHRNA3 rs1051730 genotype and short-term smoking cessation. Nicotine Tob Res, 13 982-988.

Kroll ME, Stiller CA, Murphy MF & Carpenter LM. (2011). Childhood leukaemia and socioeconomic status in England and Wales 1976-2005: evidence of higher incidence in relatively affluent communities persists over time. Br J Cancer, 105 1783-7.

Jones EA, Stewart A, Stiller C, Douglas F & Bown N. (2011). Wilms tumor incidence in children with 2q terminal deletions: A cohort study. Am J Med Genet, 155 2221-2223.

Kendall G & Fell T. (2011). Doses to the red bone marrow of young people and adults from radiation of natural origin. J Radiol Prot, 31 329-335.

Kendall G, Little MP & Wakeford R. (2011). Numbers and proportions of leukemias in young people and adults induced by radiation of natural origin. Leuk Res, 35 1039-1043.

Reulen RC, Frobisher C, Winter DL, Kelly J, Lancashire ER, Stiller CA, Pritchard-Jones K, Jenkinson HC, Hawkins MM & British Childhood Cancer Survivor Study Steering Group. (2011). Long-term risks of subsequent primary neoplasms among survivors of childhood cancer. JAMA, 305 2311-2319.

Chumas P, Kenny T & Stiller C. (2011). Subspecialisation in neurosurgery-does size matter? Acta neurochir, 153 1231-1236.

Slade I, Murray A, Hanks S, Kumar A, Walker L, Hargrave D, Douglas J, Stiller C, Izatt L & Rahman N.(2011). Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma. Fam Cancer, 10 337-342.

Slade I, Bacchelli C, Davies H, Murray A, Abbaszadeh F, Hanks S, Barfoot R, Burke A, Chisholm J, Hewitt M, Jenkinson H, King D, Morland B, Pizer B, Prescott K, Saggar A, Side L, Traunecker H, Vaidya S, Ward P, Futreal PA, Vujanic G, Nicholson AG, Sebire N, Turnbull C, Priest JR, Pritchard-Jones K, Houlston R, Stiller C, Stratton MR, Douglas J, & Rahman N.(2011). DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet., 48 273-278.

Kroll ME, Murphy MF, Carpenter LM, & Stiller CA (2011). Childhood cancer registration in Britain: capture-recapture estimates of completeness of ascertainment. Br J Cancer, 104 1227-1233.

England RJ, Haider N, Vujanic GM, Kelsey A, Stiller CA, Pritchard-Jones K & Powis M.(2011). Mesoblastic nephroma: A report of the United Kingdom children's cancer and leukaemia group (CCLG). Pediatr Blood Cancer., 56 744-748.

David SP, Johnstone EC, Churchman M, Aveyard P, Murphy MFG & Munafò MR. (2011). Pharmacogenetics of Smoking Cessation in General Practice: Results From the Patch II and Patch in Practice Trials. Nicotine and tobacco research, 13 157-167.